FS-LASIK for the treatment of moderate-to-high hyperopia.
Journal
Journal of cataract and refractive surgery
ISSN: 1873-4502
Titre abrégé: J Cataract Refract Surg
Pays: United States
ID NLM: 8604171
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
received:
09
09
2022
accepted:
26
01
2023
medline:
2
6
2023
pubmed:
7
2
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
To report modern outcomes of femtosecond laser-assisted cataract surgery (FS-LASIK) for the correction of moderate-to-high hyperopia (≥3.50 diopters [D] and ≤6.50 D), excluding low or very high hyperopia. Vissum, Alicante, Spain. Monocentric retrospective case series study. Visumax-500 kHz femtosecond laser and Amaris-750 excimer-laser were used. Eyes with at least 6 months of follow-up were included. 36-month data was collected when available. Primary outcome measure was short term efficacy and safety. Secondary outcome measure was long term stability. 6-month data of 92 eyes was collected (68 eyes at 36 months). Mean age was 34.6 ± 10.4 years. Mean treated sphere was 4.69 ± 0.87. Efficacy index was 0.91 and 0.90 at 6 months and 36 months respectively. Safety index was 1.00. Uncorrected distance visual acuity was 20/20 or better in 72%, postoperative spherical equivalent within 0.5 D in 80% (93% within 1 D), and loss of 1 line of corrected distance visual acuity (CDVA) occurred in 13% (2 or more lines in 0%). Gain of 1 or more CDVA lines occurred in 17%. A slight but significant regression was observed at 36 months. Postoperatively, 21.73% required flap lift for laser enhancement, and 11.95% an orthoptic visual rehabilitation due to accommodative disorders. Modern LASIK provides good efficacy and safety levels for the management of moderate to high hyperopia (up to +6.5 D), with levels close to those previously reported with refractive lens exchange for young hyperopia patients without presbyopia, where we defend the maintenance of LASIK as first line therapy. Risk of requiring a refractive enhancement or an orthoptic visual rehabilitation remains relevant and needs to be discussed with patients preoperatively.
Identifiants
pubmed: 36745850
doi: 10.1097/j.jcrs.0000000000001153
pii: 02158034-202306000-00004
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
558-564Informations de copyright
Copyright © 2023 Published by Wolters Kluwer on behalf of ASCRS and ESCRS.
Références
Alio JL, El Aswad A, Vega-Estrada A, Javaloy J. Laser in situ keratomileusis for high hyperopia (>5.0 diopters) using optimized aspheric profiles: efficacy and safety. J Cataract Refract Surg 2013;39:519–527
Reinstein DZ, Carp GI, Archer TJ, Day AC, Vida RS. Outcomes for hyperopic LASIK with the MEL 90 excimer laser. J Refract Surg 2018;34:799–808
Djodeyre MR, Ortega-Usobiaga J, Beltran J, Druchkiv V, Baviera-Sabater J, Bouza-Miguens C. Bilateral refractive lens exchange with trifocal intraocular lens for hyperopia in patients younger than 40 years: a case-control study. J Refract Surg 2021;37:524–531
Alio Del Barrio JL, Alio JL. Refractive lensectomy in non-presbyopic patients: just a psychological barrier or an unethical activity? J Refract Surg 2021;37:861–862
de Ortueta D, Arba-Mosquera S. Laser in situ keratomileusis for high hyperopia with corneal vertex centration and asymmetric offset. Eur J Ophthalmol 2017;27:141–152
Alio Del Barrio JL, Tiveron M, Plaza-Puche AB, Amesty MA, Casanova L, Garcia MJ, Alio JL. Laser-assisted in situ keratomileusis with optimized, fast-repetition, and cyclotorsion control excimer laser to treat hyperopic astigmatism with high cylinder. Eur J Ophthalmol 2017;27:686–693
Motwani M, Pei R. Treatment of moderate-to-high hyperopia with the WaveLight Allegretto 400 and EX500 excimer laser systems. Clin Ophthalmol 2017;11:999–1007
Dave R, O'Brart DP, Wagh VK, Lim WS, Patel P, Lee J, Marshall J. Sixteen-year follow-up of hyperopic laser in situ keratomileusis. J Cataract Refract Surg 2016;42:717–724
Gharaibeh AM, Villanueva A, Mas D, Espinosa J, Alio JL. Corneal stability following hyperopic LASIK with advanced laser ablation profiles analyzed by a light propagation study. J Ophthalmol 2018;2018:3060939
Plaza-Puche AB, Vargas V, Yebana P, Arba-Mosquera S, Alio JL. Stability of corneal topography and aberrometry after hyperopic laser in situ keratomileusis with a 500-Hz excimer laser platform: a 3-year follow-up study. Eur J Ophthalmol 2020;30:1238–1245
Moshirfar M, Megerdichian A, West WB, Miller CM, Sperry RA, Neilsen CD, Tingey MT, Hoopes PC. Comparison of visual outcome after hyperopic LASIK using a wavefront-optimized platform versus other excimer lasers in the past 2 decades. Ophthalmol Ther 2021;10:547–563
Gauthier-Fournet L, Penin F, Arba Mosquera S. Six-month outcomes after high hyperopia correction using laser-assisted in situ keratomileusis with a large ablation zone. Cornea 2019;38:1147–1153
Fernandez-Vega L, Alfonso JF, Baamonde B, Madrid-Costa D, Montes-Mico R, Lozano J. Visual and refractive outcomes in hyperopic pseudophakic patients implanted with the Acri.LISA 366D multifocal intraocular lens. Am J Ophthalmol 2009;148:214–220.e1